Flex Pharma Presenting At Two Upcoming Consumer Investor Conferences In June 2015

BOSTON--(BUSINESS WIRE)--Click to Tweet this News

Flex Pharma, Inc. (NASDAQ: FLKS), a company that is developing innovative and proprietary treatments for exercise-associated muscle cramps and nocturnal leg cramps, today announced that it will present a corporate overview at the following upcoming consumer investor conferences in June:

• The Piper Jaffray 35th Annual Consumer Conference on June 9, 2015 at 1:10 p.m. ET in New York, NY; and
• The Jefferies Global Consumer Conference on June 23, 2015 at 8:00 a.m. ET in Nantucket, MA.

A live webcast of Flex Pharma’s presentations at these conferences may be accessed in the Investor section of the Company’s website at www.flex-pharma.com. Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex Pharma’s website for 2 weeks following each presentation.

Flex Pharma also announced today that individuals can begin following the Company on twitter (@flexpharma) and the Company’s website (http://ir.flex-pharma.com/) to see the latest progress of the Company’s pre-launch activities for its consumer product to prevent and treat exercise-associated muscle cramps.

About Flex Pharma

Flex Pharma, Inc. is a company that is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions. In three randomized, blinded, placebo-controlled, cross-over studies, Flex Pharma’s proprietary treatment has shown a statistically significant reduction in the intensity of muscle cramps in healthy normal volunteers.

Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chairman and Chief Executive Officer Christoph Westphal, M.D., Ph.D.

Follow Flex Pharma on twitter (@flexpharma) and visit the Company’s web site (http://ir.flex-pharma.com/) for updates of the Company’s pre-launch activities for its consumer product to prevent and treat exercise-associated muscle cramps.